1. Home
2. News
3. Survey of clinicians’ experience and views of the MASLD diagnostic pathway

Survey of clinicians’ experience and views of the MASLD diagnostic pathway

13 September 2024

NHS England is gathering information on the current landscape, approaches and service models for diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) formerly known as non-alcoholic fatty liver disease (NAFLD). We are sharing a link that leads to a short survey to help them understand the barriers, challenges, and opportunities from a primary care perspective.

Please complete the survey which takes approximately 10 minute and can be found here by Friday 27 September.

 

View other News